Adaptive Effects of Endocrine Hormones on Metabolism of Macronutrients during Fasting and Starvation: A Scoping Review.
Reza KarimiAlina YanovichFawzy A ElbarbryAnita ClevenPublished in: Metabolites (2024)
Food deprivation can occur for different reasons. Fasting (<24 h duration) occurs to meet religious or well-being goals. Starvation (>1-day duration) occurs when there is intentional (hunger strike or treatment of a medical condition) or unintentional (anorexia nervosa, drought, epidemic famine, war, or natural disaster) food deprivation. A scoping review was undertaken using the PubMed database to explore 1805 abstracts and review 88 eligible full-text articles to explore the adaptive relationships that emerge between cortisol, insulin, glucagon, and thyroid hormones on the metabolic pathways of macronutrients in humans during fasting and starvation. The collected data indicate that fasting and starvation prime the human body to increase cortisol levels and decrease the insulin/glucagon ratio and triiodothyronine (T 3 ) levels. During fasting, increased levels of cortisol and a decreased insulin/glucagon ratio enhance glycogenolysis and reduce the peripheral uptake of glucose and glycogenesis, whereas decreased T 3 levels potentially reduce glycogenolysis. During starvation, increased levels of cortisol and a decreased insulin/glucagon ratio enhance lipolysis, proteolysis, fatty acid and amino acid oxidation, ketogenesis, and ureagenesis, and decreased T 3 levels reduce thermogenesis. We present a potential crosstalk between T 3 and the above hormones, including between T 3 and leptin, to extend their adaptive roles in the metabolism of endogenous macronutrients during food deprivation.
Keyphrases
- type diabetes
- blood glucose
- insulin resistance
- adipose tissue
- healthcare
- public health
- amino acid
- endothelial cells
- anorexia nervosa
- emergency department
- electronic health record
- blood pressure
- human health
- smoking cessation
- hydrogen peroxide
- artificial intelligence
- deep learning
- arabidopsis thaliana
- induced pluripotent stem cells
- adverse drug